Étude EURAP
Elefant, E.
la Lettre du Neurologue 16(1): 13-14
2012
ISSN/ISBN: 1276-9339
Accession: 078643246
PDF emailed within 1 workday: $29.90
Related References
The Lancet Neurology 2011: EURAP signals a new era in epilepsy research Lancet. Neurology 10(7): 591Senf, P.; Schmitz, B. 2011: EURAP-Register Antiepileptika in der Schwangerschaft Der Gynäkologe 44(12): 963-968
Kretz, R.; Coban, I.; Gaus, V.; Schmitz, B. 2006: EURAP: the European Registry of Antiepileptic Drugs and Pregnancy Der Nervenarzt 77(6): 722; 724-728
Tomson, Törn.; Battino, D.; Bonizzoni, E.; Craig, J.; Lindhout, D.; Perucca, E.; Sabers, A.; Vajda, F. 2004: EURAP: an international registry of antiepileptic drugs and pregnancy Epilepsia 45(11): 1463-1464
Pennell, P.B. 2006: EURAP outcomes for seizure control during pregnancy: useful and encouraging data Epilepsy Currents 6(6): 186-188
Braillon, A.; Bewley, S. 2018: EURAP registry: inadequate monitoring of prescribed drugs in pregnancy Lancet. Neurology 17(9): 741
Rapcencu, A.E.; Lindhout, D.; Bulk, S. 2012: Frequently asked questions on epilepsy, pregnancy and lactation: a EURAP-NL report Seizure 21(8): 606-609
Tomson, T.ör.; Battino, D.; Bonizzoni, E.; Craig, J.J.; Lindhout, D.; Perucca, E.; Sabers, A.; Thomas, S.V.; Vajda, F. 2015: Antiepileptic drugs and intrauterine death: a prospective observational study from EURAP Neurology 85(7): 580-588
Tomson, T.ör.; Battino, D.; Bonizzoni, E.; Craig, J.; Lindhout, D.; Perucca, E.; Sabers, A.; Thomas, S.V.; Vajda, F. 2016: Withdrawal of valproic acid treatment during pregnancy and seizure outcome: Observations from EURAP Epilepsia 57(8): E173-E177
Tomson, T.; Battino, D.; Beaussart, M.; Bonizzoni, E.; Craig, J.; Lindhout, D.; Perucca, E.; Vajda, F. 2001: EURAP An international pregnancy registry for the evaluation of the comparative teratogenic effects of antiepileptic drugs Epilepsia 42(Suppl 7): 293
Battino, D.; Bonizzoni, E.; Craig, J.; Lindhout, D.; Perucca, E.; Sabers, A.; Vajda, F.; Tomson, T.ör. 2009: Utilization of antiepileptic drugs during pregnancy: comparative patterns in 38 countries based on data from the EURAP registry Epilepsia 50(10): 2305-2309
Vossler, D.G. 2019: Comparative Risk of Major Congenital Malformations with 8 Different Antiepileptic Drugs: a Prospective Cohort Study of the EURAP Registry Epilepsy Currents 19(2): 83-85
Tomson, T.ör.; Battino, D.; Bonizzoni, E.; Craig, J.; Lindhout, D.; Perucca, E.; Sabers, A.; Thomas, S.V.; Vajda, F.; Faravelli, F.; Pantaleoni, C.; Robert-Gnansia, E.; Cabral-Lim, L.; Čebular, B.št.; De Marinis, A.; Kälviäinen, R.; Khomeriki, K.; Kiteva-Trencevska, G.; Kochen, S.; Kurthen, M.; Luef, G.; Martinez Ferri, M.; Milovanović, M.; Nakken, K.O.; Neufeld, M.; Ohtani, H.; Russell, A.; Safcák, V.ír.; Schmitz, B.; Specchio, L.M.; Tettenborn, B.; van Puijenbroek, E.; Yu, H.-Y.; Zarubova, J.; Albretsen, C.; Alvestad, S.; Andersen, N.B.; Antonini, L.; Arentsen, J.; Aurlien, D.; Barzinji, I.; Becerra Cuñat, J.L.; Bohorquez Morera, N.; Brodie, M.J.; Brodtkorb, E.; Broglio, L.; Bruun Christensen, E.; Bušek, P.; Cagnetti, C.; Canevi 2018: Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry LANCET. Neurology 17(6): 530-538
Kaplan, Y.C.; Nulman, I.; Koren, G. 2015: Dose-Dependent Risk of Malformations with Antiepileptic Drugs: An Analysis of Data from the EURAP Epilepsy and Pregnancy Registry Therapeutic Drug Monitoring 37(5): 557-558
Tomson, T.ör.; Battino, D.; Bonizzoni, E.; Craig, J.; Lindhout, D.; Sabers, A.; Perucca, E.; Vajda, F. 2011: Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry LANCET. Neurology 10(7): 609-617